(19)
(11) EP 3 993 805 A1

(12)

(43) Date of publication:
11.05.2022 Bulletin 2022/19

(21) Application number: 20737381.2

(22) Date of filing: 29.06.2020
(51) International Patent Classification (IPC): 
A61K 31/5415(2006.01)
A61P 25/28(2006.01)
A61K 45/06(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/5415; A61K 45/06; A61P 25/28; A61K 31/27
 
C-Sets:
  1. A61K 31/5415, A61K 2300/00;
  2. A61K 31/27, A61K 2300/00;

(86) International application number:
PCT/EP2020/068306
(87) International publication number:
WO 2021/001326 (07.01.2021 Gazette 2021/01)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 02.07.2019 GB 201909506

(71) Applicant: WisTa Laboratories Ltd.
Singapore 658066 (SG)

(72) Inventors:
  • RIEDEL, Gernot
    Aberdeen Aberdeenshire AB25 2ZD (GB)
  • WISCHIK, Claude Michel
    Aberdeen Aberdeenshire AB24 5RP (GB)
  • HARRINGTON, Charles Robert
    Aberdeen Aberdeenshire AB25 2ZD (GB)

(74) Representative: Mewburn Ellis LLP 
Aurora Building Counterslip
Bristol BS1 6BX
Bristol BS1 6BX (GB)

   


(54) METHYLTHIONINIUM FOR USE IN THE TREATMENT OF SYNAPTOPATHIES